Parkinson's disease


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Parkinson's disease: Alzheimer's disease, dopamine

Par·kin·son's disease

 (pär′kĭn-sənz) also Par·kin·son disease (-sən)
n.
A progressive disease of the central nervous system, associated with the destruction of brain cells that produce dopamine and characterized by muscle tremors, muscle rigidity or stiffness, abnormally slow movement, and impaired balance and coordination. It usually affects people over the age of 50. Also called paralysis agitans.

[After James Parkinson (1755-1824), British physician.]

Parkinson's disease

(ˈpɑːkɪnsənz)
n
(Pathology) a progressive chronic disorder of the central nervous system characterized by impaired muscular coordination and tremor. Often shortened to: Parkinson's Also called: Parkinsonism, Parkinson's syndrome, paralysis agitans or shaking palsy
[C19: named after James Parkinson (1755–1824), British surgeon, who first described it]

Par′kin•son's disease`

(ˈpɑr kɪn səns)
n.
a neurologic disease believed to be caused by deterioration of the brain cells that produce dopamine, occurring primarily after the age of 60, and characterized by tremors, esp. of the fingers and hands, muscle rigidity, and a shuffling gait. Also called par′kin•son•ism (-səˌnɪz əm)
[1870–75; after James Parkinson (1755–1824), English physician who first described it]

Par·kin·son's disease

(pär′kĭn-sənz)
A disease of the brain, usually in older people, that tends to become more severe over time. Symptoms include shaking, slowed movement, and rigid muscles.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Parkinson's disease - a degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination
tremor - shaking or trembling (usually resulting from weakness or stress or disease)
degenerative disorder - condition leading to progressive loss of function
brain disease, brain disorder, encephalopathy - any disorder or disease of the brain
Translations

Parkinson's disease

[ˈpɑːkɪnsənzdɪˌziːz] Nenfermedad f de Parkinson

Parkinson's disease

n. enfermedad de Parkinson, atrofia o degeneración de los nervios cerebrales que se manifiesta con temblores, debilidad muscular progresiva, cambios en el habla, la manera de andar y la postura.
References in periodicals archive ?
New research published in the European Journal of Neurology indicates that an active sexual life is linked with a lower disability and better quality of life in men with early Parkinson's disease.
What to expect from the Global Parkinson's Disease Treatment Market report?
Parkinson's disease is a progressive nervous system disorder that affects movement.
Swedish biopharma company BioArctic AB (Nasdaq Stockholm:BIOA B) reported on Wednesday the launch of the first clinical study of ABBV-0805 in the US for Parkinson's disease.
Parkinson's disease is characterized by the death of nerve cells in the substantia nigra region of the brain.
Aiming to develop treatments for Parkinson's disease, this research group utilized neural progenitor cells induced from iPS cells derived from patients with familial Parkinson's disease and established a differentiation protocol for the stable supply of a large number of dopaminergic neurons.
Dr Qasim Bashir President Pakistan Stroke Society and Associate Professor Neurology, CMH Lahore said, 'The average age of diagnosis is around 60, but approximately 15% of people with Parkinson's are diagnosed before age 50 and are said to have young-onset Parkinson's disease.
LAHORE -- An estimated six million people worldwide are suffering from Parkinson's disease and each year around 50,000 people are diagnosed with PD globally, reveal leading neurologists in a statement to mark World Parkinson's Awareness Week.
In the European Union (EU), approximately 1.2 million people have their lives impacted by Parkinson's Disease.
The transplant completes the dosing of the second cohort of the clinical trial for Parkinson's disease.
A model of the motor circuit is described in normal condition and its alteration in Parkinson's disease is described since 1980 with some limitations.
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

Full browser ?